Followers | 129 |
Posts | 23648 |
Boards Moderated | 1 |
Alias Born | 09/14/2016 |
![](https://investorshub.advfn.com/uicon/575956.png?cb=1599739188)
Monday, August 09, 2021 2:14:22 PM
Recent SILO News
- Silo Pharma Secures Exclusive Global License for Alzheimer's Therapeutic • GlobeNewswire Inc. • 07/16/2024 10:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 07/08/2024 08:15:15 PM
- Silo Pharma Announces Exclusive, Global License for Lead Candidate SPC-15 Targeting PTSD and Stress-Induced Anxiety Disorders • GlobeNewswire Inc. • 07/08/2024 12:45:00 PM
- Silo Pharma Partners with AmplifyBio to Advance SPC-15 for PTSD and Anxiety • GlobeNewswire Inc. • 06/26/2024 12:50:00 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 06/13/2024 09:08:53 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 06/13/2024 05:19:05 PM
- Form D - Notice of Exempt Offering of Securities • Edgar (US Regulatory) • 06/11/2024 08:00:43 PM
- Silo Pharma Announces Successful Production of its SP-26 Ketamine Implant for Fibromyalgia • GlobeNewswire Inc. • 06/07/2024 12:18:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/06/2024 08:52:32 PM
- Silo Pharma Announces Closing of $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 06/06/2024 08:50:00 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 06/06/2024 10:07:51 AM
- Silo Pharma Announces $2 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules • GlobeNewswire Inc. • 06/05/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 06/04/2024 08:05:28 PM
- Silo Pharma Submits Pre-Investigational New Drug Application to FDA for SPC-15 as a Treatment for PTSD and Anxiety • GlobeNewswire Inc. • 06/04/2024 12:41:00 PM
- Silo Pharma Announces Positive Results from Study for Depression Treatment, Remission, and Relapse Prevention • GlobeNewswire Inc. • 05/21/2024 12:45:00 PM
- Silo Pharma to Participate in FDA Meeting Exploring Emerging Therapeutic Interest in Ketamine • GlobeNewswire Inc. • 05/14/2024 12:45:00 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/13/2024 08:05:59 PM
- Silo Pharma Announces Positive Results for Intranasal PTSD Treatment • GlobeNewswire Inc. • 04/23/2024 12:15:00 PM
- Silo Pharma set to Acquire Exclusive Licensing for Promising Alzheimer’s Disease Therapeutic • GlobeNewswire Inc. • 04/10/2024 12:11:00 PM
- Silo Pharma Exercises Option for Exclusive License Agreement for First-in-Class PTSD and Stress-Induced Anxiety Therapeutic • GlobeNewswire Inc. • 03/20/2024 12:30:00 PM
- Silo Pharma Files Patent for Groundbreaking Ketamine Implant Therapeutic to Target Fibromyalgia and Chronic Pain • GlobeNewswire Inc. • 03/18/2024 11:15:00 AM
- Silo Pharma Completes Successful Dose-Ranging Study of SPC-15 Intranasal Therapeutic for PTSD • GlobeNewswire Inc. • 02/28/2024 01:25:00 PM
- Silo Pharma’s SP-26 Ketamine Implant Demonstrates Successful Drug Delivery • GlobeNewswire Inc. • 02/14/2024 01:45:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 06:15:35 PM
- Silo Pharma Announces Pipeline Prioritization for 2024 Targeting Mental Health, Chronic Pain, and Neurology • GlobeNewswire Inc. • 02/01/2024 03:00:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM
HealthLynked Expands Telemedicine Nationwide • HLYK • Jul 17, 2024 8:00 AM
Peer To Peer Network aka Mobicard™ Launches AI Investor Chatbot Boosting Engagement & Lead Generation on Ihub • PTOP • Jul 15, 2024 8:30 AM
Greenlite Ventures Announces AI Integration into No Limit Platforms • GRNL • Jul 15, 2024 8:00 AM
Cannabix Technologies and Omega Laboratories Inc. Provide Positive Developments on Marijuana Breathalyzer Testing • BLO • Jul 11, 2024 8:21 AM